H17.02 Adherent leukoma, left eye

Name of the Condition

• Adherent leukoma, left eye

Summary

Adherent leukoma is a condition characterized by a white, scar-like opacity on the cornea that adheres to the underlying tissue. This opacity results from corneal inflammation or injury, leading to fibrous tissue formation. The condition may impair vision depending on the size, location, and density of the opacity. It is often a sequelae of prior corneal damage, such as infection, trauma, or surgery.

Causes

Adherent leukoma typically develops following corneal injury, infection, or inflammation. Common precipitating events include corneal ulcers, herpetic keratitis, chemical burns, or surgical procedures like corneal transplantation. The opacity forms as part of the healing process, where fibrous tissue replaces normal corneal tissue, leading to adhesion and clouding.

Risk Factors

• Prior corneal trauma or surgery
• History of corneal infections (e.g., bacterial, viral)
• Chemical or thermal injury to the eye
• Chronic corneal inflammation or dystrophies
• Prolonged use of contact lenses with poor hygiene
• Systemic conditions affecting corneal health (e.g., autoimmune disorders)

Symptoms

• Blurred or reduced vision
• Visible white opacity on the cornea
• Sensitivity to light (photophobia)
• Eye discomfort or pain
• Difficulty with night vision or glare
• Possible redness or irritation

Diagnosis

Diagnosis involves a comprehensive eye examination, including slit-lamp biomicroscopy to assess the corneal opacity and its adherence. Visual acuity testing evaluates the impact on vision. Additional tests, such as corneal topography or anterior segment imaging, may be used to determine the extent of the opacity and rule out other conditions. A thorough patient history, including prior eye injuries or surgeries, aids in confirming the diagnosis.

Treatment Options

Treatment depends on the severity of vision impairment and the opacity’s characteristics. Mild cases may not require intervention beyond monitoring. For significant vision loss, options include corneal transplantation (penetrating keratoplasty) to replace the scarred tissue. In some cases, superficial keratectomy may be performed to remove the opacity if it is superficial. Visual rehabilitation with glasses or contact lenses may help improve vision if the opacity is not too dense.

Prognosis and Follow-Up

Prognosis varies based on the opacity’s size, location, and impact on vision. Surgical intervention can restore vision in many cases, but outcomes depend on the underlying corneal health and the success of the procedure. Regular follow-up with an ophthalmologist is essential to monitor for complications, such as graft rejection or recurrence of opacity, and to adjust treatment as needed.

Complications

Potential complications include permanent vision loss if the opacity is dense or centrally located, corneal neovascularization, or increased risk of infection due to corneal irregularities. Surgical treatments carry risks like graft failure, astigmatism, or inflammation. Chronic eye discomfort or photophobia may persist in some cases.

Lifestyle & Prevention

Protecting the eyes from injury by wearing appropriate safety gear during activities with a risk of eye trauma can help prevent adherent leukoma. Prompt treatment of corneal infections or injuries reduces the likelihood of scarring. Maintaining good contact lens hygiene and avoiding exposure to harmful chemicals or irritants also lowers risk. Regular eye exams help detect early changes in corneal health.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, eye pain, increased sensitivity to light, or visible corneal opacity. These symptoms may indicate a new or worsening condition requiring evaluation. Follow up with an ophthalmologist if vision problems persist or worsen over time, as early intervention can improve outcomes.

Tips for Medical Coders

Document the laterality (left eye) clearly in the medical record, as it is a key component of the code H17.02. Ensure the diagnosis is supported by clinical findings, such as slit-lamp examination results or visual acuity measurements. If the condition is bilateral, use the appropriate bilateral code or document each eye separately. Verify that the code aligns with the specific eye affected to ensure accurate coding.